VERAXA Biotech AG (VRXA)
NASDAQ: VRXA · Real-Time Price · USD
9.46
-11.80 (-55.50%)
At close: Jun 16, 2026, 4:00 PM EDT
8.20
-1.26 (-13.32%)
After-hours: Jun 16, 2026, 7:59 PM EDT
VERAXA Biotech AG Market Cap
VERAXA Biotech AG has a market cap or net worth of $238.56 million as of June 16, 2026. Its market cap has decreased by -8.37% in one year.
Market Cap
238.56M
Enterprise Value
n/a
1-Year Change
-8.37%
Ranking
Category
Stock Price
$9.46
Market Cap Chart
Since September 30, 2024, VERAXA Biotech AG's market cap has decreased from $252.24M to $238.56M, a decrease of -5.43%. That is a compound annual growth rate of -3.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 238.56M | -11.63% |
| Dec 31, 2025 | 269.95M | 6.49% |
| Dec 30, 2024 | 253.51M | 0.50% |
| Sep 30, 2024 | 252.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ginkgo Bioworks Holdings | 533.05M |
| Prime Medicine | 525.60M |
| XOMA Royalty | 524.09M |
| Cabaletta Bio | 518.51M |
| Altimmune | 515.36M |
| ProKidney | 504.44M |
| Valneva SE | 501.95M |
| Kyverna Therapeutics | 499.98M |